• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人遗传性代谢病患者的智力障碍和神经认知障碍:英国单中心经验。

Intellectual Disabilities and Neurocognitive Impairment in Adult Patients with Inherited Metabolic Diseases: A UK Single Centre Experience.

机构信息

Department of Diabetes and Endocrinology, Salford Royal Organisation, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UK.

The School of Medicine and Manchester Academic Health Sciences Centre, The University of Manchester, Manchester M13 9PL, UK.

出版信息

Genes (Basel). 2024 Jul 15;15(7):923. doi: 10.3390/genes15070923.

DOI:10.3390/genes15070923
PMID:39062702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11276493/
Abstract

Inherited metabolic diseases (IMDs) are a group of heterogeneous genetic disorders resulting in substrate accumulation, energy deficiency, or complex molecular defects due to the failure of specific molecules to act as enzymes, cofactors, transporters, or receptors in specific metabolic pathways. The pathophysiological changes seen in IMDs are sometimes associated with intellectual disability (ID) or neurocognitive decline, necessitating multidisciplinary input. We here describe our experience at one tertiary metabolic centre in the UK. We reviewed the case prevalence and existing service provision in one adult IMD service covering a multi-ethnic population of 10 million in North England. In our cohort of 2268 IMD patients, 1598 patients had general metabolic conditions (70.5%), and 670 had lysosomal storage disease/disorders (LSD)s (29.5%). The overall prevalence of ID and neurocognitive decline was found to be 15.7% ( = 357), with patients with LSDs accounting for 23.5% ( = 84) of affected patients. Given the prevalence of ID in adults with IMDs, access to multidisciplinary input from neuropsychology and neuropsychiatry services is important. Education of healthcare professionals to diagnose IMDs in patients with ID, in addition to neurocognitive and neuropsychiatric presentations, will avoid missed diagnoses of IMD and will have a positive effect on patient outcomes.

摘要

遗传性代谢疾病(IMDs)是一组异质性遗传疾病,由于特定分子无法作为酶、辅助因子、转运体或受体在特定代谢途径中发挥作用,导致底物积累、能量不足或复杂的分子缺陷。IMDs 中观察到的病理生理变化有时与智力残疾(ID)或神经认知能力下降有关,需要多学科的投入。我们在这里描述了我们在英国一个三级代谢中心的经验。我们回顾了一个覆盖英格兰北部 1000 万人口的多民族人群的一个成人 IMD 服务的病例患病率和现有服务提供情况。在我们的 2268 名 IMD 患者队列中,1598 名患者患有一般代谢疾病(70.5%),670 名患者患有溶酶体贮积症/疾病(LSD)(29.5%)。发现 ID 和神经认知能力下降的总患病率为 15.7%(=357),LSD 患者占受影响患者的 23.5%(=84)。鉴于 IMD 成年患者的 ID 患病率,获得神经心理学和神经精神病学服务的多学科投入很重要。教育医疗保健专业人员诊断 ID 患者中的 IMD,除了神经认知和神经精神病学表现外,还将避免 IMD 的漏诊,并对患者的结局产生积极影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/11276493/498edecd72b8/genes-15-00923-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/11276493/31817c4a55f4/genes-15-00923-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/11276493/351b2a7f8505/genes-15-00923-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/11276493/228337abb365/genes-15-00923-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/11276493/498edecd72b8/genes-15-00923-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/11276493/31817c4a55f4/genes-15-00923-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/11276493/351b2a7f8505/genes-15-00923-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/11276493/228337abb365/genes-15-00923-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/11276493/498edecd72b8/genes-15-00923-g004.jpg

相似文献

1
Intellectual Disabilities and Neurocognitive Impairment in Adult Patients with Inherited Metabolic Diseases: A UK Single Centre Experience.成人遗传性代谢病患者的智力障碍和神经认知障碍:英国单中心经验。
Genes (Basel). 2024 Jul 15;15(7):923. doi: 10.3390/genes15070923.
2
100 years of inherited metabolic disorders in Austria-A national registry of minimal birth prevalence, diagnosis, and clinical outcome of inborn errors of metabolism in Austria between 1921 and 2021.100 年遗传性代谢疾病在奥地利-1921 年至 2021 年奥地利先天性代谢错误最小出生流行率、诊断和临床结局的国家登记
J Inherit Metab Dis. 2022 Mar;45(2):144-156. doi: 10.1002/jimd.12442. Epub 2021 Oct 17.
3
Standardized emergency protocols to improve the management of patients with suspected or confirmed inherited metabolic disorders (IMDs): An initiative of the French IMDs Healthcare Network for Rare Diseases.标准化急救方案以提升疑似或确诊遗传性代谢疾病(IMD)患者的管理:法国遗传性代谢疾病罕见病医疗保健网的一项倡议。
Mol Genet Metab. 2024 Sep-Oct;143(1-2):108579. doi: 10.1016/j.ymgme.2024.108579. Epub 2024 Sep 14.
4
The incidence of inherited metabolic disorders in the West Midlands, UK.英国西米德兰兹郡遗传性代谢疾病的发病率。
Arch Dis Child. 2006 Nov;91(11):896-9. doi: 10.1136/adc.2005.091637. Epub 2006 May 11.
5
[Inborn errors of metabolism are not hopeless; early identification of treatable conditions in children with intellectual disability].[先天性代谢缺陷并非毫无希望;早期识别智力残疾儿童中可治疗的病症]
Ned Tijdschr Geneeskd. 2014;158:A8042.
6
Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app.可治疗的遗传性代谢障碍导致的智力障碍:2021 年回顾和数字应用程序。
Orphanet J Rare Dis. 2021 Apr 12;16(1):170. doi: 10.1186/s13023-021-01727-2.
7
A Population-Based Genomic Study of Inherited Metabolic Diseases Detected Through Newborn Screening.一项基于人群的通过新生儿筛查发现的遗传性代谢疾病基因组研究。
Ann Lab Med. 2016 Nov;36(6):561-72. doi: 10.3343/alm.2016.36.6.561.
8
Psychiatric service use and psychiatric disorders in adults with intellectual disability.成年智力残疾者的精神科服务利用情况与精神障碍
J Intellect Disabil Res. 2008 Nov;52(11):986-95. doi: 10.1111/j.1365-2788.2008.01124.x.
9
Inherited metabolic disorders in Turkish patients with autism spectrum disorders.土耳其自闭症谱系障碍患者的遗传性代谢紊乱。
Autism Res. 2016 Feb;9(2):217-23. doi: 10.1002/aur.1507. Epub 2015 Jun 7.
10
Neuropsychiatric risk in children with intellectual disability of genetic origin: IMAGINE, a UK national cohort study.遗传性智力障碍儿童的神经精神风险:想象,一项英国全国队列研究。
Lancet Psychiatry. 2022 Sep;9(9):715-724. doi: 10.1016/S2215-0366(22)00207-3. Epub 2022 Aug 3.

本文引用的文献

1
Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses.迟发性 GM2 神经节苷脂贮积症疾病负担和进展的临床结局评估。
Mol Genet Metab. 2024 Jul;142(3):108512. doi: 10.1016/j.ymgme.2024.108512. Epub 2024 Jun 6.
2
A one-year pilot study comparing direct-infusion high resolution mass spectrometry based untargeted metabolomics to targeted diagnostic screening for inherited metabolic diseases.一项为期一年的试点研究,比较基于直接进样高分辨率质谱的非靶向代谢组学与遗传性代谢疾病的靶向诊断筛查。
Front Mol Biosci. 2023 Nov 2;10:1283083. doi: 10.3389/fmolb.2023.1283083. eCollection 2023.
3
Inherited metabolic disorders in adults: systematic review on patient characteristics and diagnostic yield of broad sequencing techniques (exome and genome sequencing).
成人遗传性代谢紊乱:关于患者特征及广泛测序技术(外显子组和基因组测序)诊断率的系统评价
Front Neurol. 2023 Jul 25;14:1206106. doi: 10.3389/fneur.2023.1206106. eCollection 2023.
4
Biochemical, Genetic and Clinical Diagnostic Approaches to Autism-Associated Inherited Metabolic Disorders.自闭症相关遗传性代谢疾病的生化、遗传和临床诊断方法。
Genes (Basel). 2023 Mar 27;14(4):803. doi: 10.3390/genes14040803.
5
Genome-Wide Sequencing Modalities for Children with Unexplained Global Developmental Delay and Intellectual Disabilities-A Narrative Review.不明原因的全面发育迟缓及智力障碍儿童的全基因组测序方式——一篇叙述性综述
Children (Basel). 2023 Mar 3;10(3):501. doi: 10.3390/children10030501.
6
Genetic Diagnosis in a Cohort of Adult Patients with Inherited Metabolic Diseases: A Single-Center Experience.遗传诊断在一组遗传性代谢疾病成年患者中的应用:单中心经验。
Biomolecules. 2022 Jun 30;12(7):920. doi: 10.3390/biom12070920.
7
Cognitive impairment and associated factors among mature and older adults living in the community of Gondar town, Ethiopia, 2020.2020 年,埃塞俄比亚贡德尔镇社区中成年和老年人的认知障碍及相关因素。
Sci Rep. 2022 May 9;12(1):7545. doi: 10.1038/s41598-022-11735-2.
8
Quantitative brain MRI morphology in severe and attenuated forms of mucopolysaccharidosis type I.严重和轻度黏多糖贮积症Ⅰ型的定量脑 MRI 形态学研究。
Mol Genet Metab. 2022 Feb;135(2):122-132. doi: 10.1016/j.ymgme.2022.01.001. Epub 2022 Jan 7.
9
Undiagnosed Phenylketonuria Can Exist Everywhere: Results From an International Survey.未诊断的苯丙酮尿症可能无处不在:一项国际调查结果。
J Pediatr. 2021 Dec;239:231-234.e2. doi: 10.1016/j.jpeds.2021.08.070. Epub 2021 Aug 30.
10
Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app.可治疗的遗传性代谢障碍导致的智力障碍:2021 年回顾和数字应用程序。
Orphanet J Rare Dis. 2021 Apr 12;16(1):170. doi: 10.1186/s13023-021-01727-2.